Skip to content

A non-invasive, multi-dimensional study of early detection of prostate cancer with urine

A non-invasive, multi-dimensional study of early detection of prostate cancer with urine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071837
Enrollment
Unknown
Registered
2023-05-26
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

Index test:DNA mutation analysis,DNA methylation analysis

Sponsors

Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Recent PSA is located in the grey area (4 ng/ml < PSA < 20 ng/ml) and scheduled for prostate cancer screening; 2. Understand and acceptable the meaning of the research; 3. Acceptable for inspection after 2 years of follow-up survey;

Exclusion criteria

Exclusion criteria: 1. Process of prostate biopsy in recent 6 months; 2. The previous diagnosis of prostate cancer; 3. To prostate surgery before, such as TURP (transurethral resection of the prostate); 4. Uncontrolled severe infection.

Design outcomes

Primary

MeasureTime frame
DNA mutation analysis;DNA methylation analysis;Sensitivity;Specificity;

Secondary

MeasureTime frame
DNA copy-number aberrations;

Countries

China

Contacts

Public ContactNianzeng Xing

Chinese Academy of Medical Sciences and Peking Union Medical College

nianzeng2006@vip.sina.com+86 186 0123 8866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026